Historical record - last NADAC publication: 3/23/2022
Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1396 per EA under NDC 00054022321. Its NADAC has been published 436 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054022321
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
3/23/2022
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090749On Market Since
3/27/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 436 times since Nov 28, 2013, and over the history we have for it it has declined 69.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1396 per EA |
|---|---|
| All-time high | $0.4855 (Feb 12, 2014) |
| All-time low | $0.1396 (Mar 23, 2022) |
| Median price | $0.2312 |
| Average price | $0.2678 |
| Largest weekly change | -20.3% (Mar 23, 2022) |
| Weeks tracked | 436 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1396 per EA (NDC 00054022321), effective Mar 30, 2022.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 69.3%. It has been tracked across 436 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1396 (Mar 23, 2022) to a high of $0.4855 (Feb 12, 2014), with a median of $0.2312 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
7 NADAC-published products share the same active ingredient, strength, and dosage form as QUETIAPINE FUMARATE 300 MG TAB, but none are currently priced below it.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 00054022321) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification